K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 376 JPY 0.3% Market Closed
Market Cap: 165.7B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note
Kaken Pharmaceutical Co Ltd
/
Cash Flow Statement
/
Cash from Financing Activities

Kaken Pharmaceutical Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kaken Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
K
Kaken Pharmaceutical Co Ltd
TSE:4521
Cash from Financing Activities
-¥5.7B
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
6%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Financing Activities
¥19.7B
CAGR 3-Years
N/A
CAGR 5-Years
-63%
CAGR 10-Years
-13%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Financing Activities
-¥198.6B
CAGR 3-Years
1%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Cash from Financing Activities
-¥39.7B
CAGR 3-Years
26%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Financing Activities
-¥139.3B
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-19%
Astellas Pharma Inc
TSE:4503
Cash from Financing Activities
¥437.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Kaken Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-5.7B JPY

Based on the financial report for Jun 30, 2024, Kaken Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -5.7B JPY.

What is Kaken Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
6%

Over the last year, the Cash from Financing Activities growth was 19%. The average annual Cash from Financing Activities growth rates for Kaken Pharmaceutical Co Ltd have been 14% over the past three years , 10% over the past five years , and 6% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 198,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.